Incidence of Symptomatic Hemorrhage in Patients With Lobar Microbleeds

Background and Purpose— Lobar microbleeds suggestive of cerebral amyloid angiopathy (CAA) are often identified on MRI in the absence of lobar intracerebral hemorrhage (ICH). We compared the baseline characteristics and risk of subsequent ICH among such patients to those presenting with CAA-related lobar ICH. Methods— Clinical data (demographics, risk factors), apolipoprotein E genotype, neuroimaging markers of CAA severity (microbleed counts, leukoaraiosis volume), and clinical outcomes (incidence rates of ICH and death during a mean follow-up of 5.3±3.8 years) were compared between 63 patients enrolled because of incidentally found microbleeds and 316 with CAA-related ICH, in our prospectively enrolled cohort. Predictors of incident ICH were explored in the microbleed-only patients using multivariable Cox regression models. Results— Microbleed-only patients shared similar demographic, apolipoprotein E, and vascular risk profiles with lobar ICH patients, but had more lobar microbleeds (median, 10 versus 2; P<0.001) and higher leukoaraiosis volumes (median, 31 versus 23 mL; P=0.02). Microbleed-only patients had a nontrivial incidence rate of ICH, not different from patients presenting with ICH (5 versus 8.9 per 100 person-years; adjusted hazard ratio, 0.58; 95% confidence interval, 0.31–1.06; P=0.08). Microbleed-only patients had a higher mortality rate (hazard ratio, 1.67; 95% confidence interval, 1.1–2.6) compared with ICH survivors. Warfarin use and increasing age were independent predictors of future ICH among microbleed-only patients after correction for other covariates. Conclusions— Patients presenting with isolated lobar microbleeds on MRI have a genetic, neuroimaging, and hemorrhagic risk profile suggestive of severe CAA pathology. They have a substantial risk of incident ICH, potentially affecting decisions regarding anticoagulation in clinical situations.

[1]  D. Hanley,et al.  Spontaneous Intracerebral Hemorrhage , 2012, Neuromethods.

[2]  A. Hofman,et al.  Cerebral microbleeds and the risk of mortality in the general population , 2013, Alzheimer's & Dementia.

[3]  Keith A. Johnson,et al.  Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study , 2013, Annals of neurology.

[4]  D. Y. Lee,et al.  Lipoprotein Phospholipase A2 and Cerebral Microbleeds in the Framingham Heart Study , 2012, Stroke.

[5]  Keith A. Johnson,et al.  Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy , 2012, Neurology.

[6]  Javier M Romero,et al.  Apolipoprotein E Genotype Predicts Hematoma Expansion in Lobar Intracerebral Hemorrhage , 2012, Stroke.

[7]  J. Baron,et al.  Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. , 2011, Brain : a journal of neurology.

[8]  N. Sattar,et al.  Cerebral Microbleeds Are Predictive of Mortality in the Elderly , 2011, Stroke.

[9]  X. Estivill,et al.  Variants at APOE influence risk of deep and lobar intracerebral hemorrhage , 2010, Annals of neurology.

[10]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[11]  Eric E. Smith,et al.  Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy , 2010, Neurology.

[12]  M. van Buchem,et al.  Descriptive Analysis of the Boston Criteria Applied to a Dutch-Type Cerebral Amyloid Angiopathy Population , 2009, Stroke.

[13]  Rebecca A Betensky,et al.  Microbleeds Versus Macrobleeds: Evidence for Distinct Entities , 2009, Stroke.

[14]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[15]  S. Greenberg,et al.  Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? , 2008, Stroke.

[16]  Istvan Csapo,et al.  Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging , 2008, Stroke.

[17]  O. Lopez,et al.  Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  Chris Rorden,et al.  Improving Lesion-Symptom Mapping , 2007, Journal of Cognitive Neuroscience.

[19]  M. Frosch,et al.  Course of cerebral amyloid angiopathy–related inflammation , 2007, Neurology.

[20]  Eric E. Smith,et al.  Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy , 2006, Neurology.

[21]  M. Frosch,et al.  The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic , 2006 .

[22]  W. Hauser,et al.  The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics , 2005, Neurology.

[23]  S. Greenberg,et al.  White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage , 2004, Neurology.

[24]  Eric E. Smith,et al.  Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage , 2004, Stroke.

[25]  D. Singer,et al.  The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. , 2004, Archives of internal medicine.

[26]  D. Singer,et al.  Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis , 2003, Stroke.

[27]  S. Greenberg,et al.  Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria , 2003, Current atherosclerosis reports.

[28]  K. Furie,et al.  Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. , 2000, The New England journal of medicine.

[29]  Yu-Min Kuo,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[30]  H. Ellis.  stroke , 1997, The Lancet.

[31]  J. Vonsattel,et al.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.

[32]  H. Vinters.  Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.

[33]  O. Levin,et al.  [Cerebral amyloid angiopathy]. , 2014, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[34]  D. Y. Lee,et al.  Lipoprotein Phospholipase A 2 and Cerebral Microbleeds in the Framingham Heart Study , 2012 .

[35]  J. Growdon,et al.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. , 2006, Neurology.

[36]  M. Frosch,et al.  The cerebral beta-amyloid angiopathies: hereditary and sporadic. , 2006, Brain pathology.

[37]  L. R. Caplan,et al.  Intracerebral haemorrhage , 1992, The Lancet.